Health TrialsbyHealthPanel

Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)

ConditionsAlzheimer Disease or Associated DisorderDementiaCognitive Decline
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age60+
SponsorOnward Health, Inc

About this trial

The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-curb (C2C) rideshare services. he main question it aims to answer is:

Do D2D rideshare services reduce missed medical appointment rates compared to C2C rideshare services?

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

All participants (or their surrogate) have the capacity to agree to allow Onward service for transportation;

have scheduled medical appointments at partner practices of Onward;

ages 60+

community-dwelling;

Disqualifiers

current enrollment in another transportation study;

already using any type of free or heavily subsized transportation service;

enrollees with comfort care only;

Not wheelchair bound, e.g. if using a wheelchair must be foldable and must be able to transfer

Trial design

Design model

Parallel

Treatments tested in this trial

  • Door-through-door companion rideshare

    Other intervention

    Door-through-Door Companion Drivers, unlike traditional rideshare services, are certified in CPR and first aid, and undergo onboard training to support older adults, individuals with mobility impairments, and those with AD/ADRD. They are trained to observe behaviors of AD/ADRD patients, monitor and detect risk of falls, elopement, and other events that may require extra assistance or emergency care during transport. Drivers accompany riders continuously until they can hand off riders to clinicians or other caregivers, or return them to their home. Technology features in the rideshare platform enable continuity of care, for consistent rider-driver matching and matching of riders to drivers based on support needs.

  • Curb-to-curb rideshare services

    Other intervention

    Curb to curb rideshare services provided by a transportation network company (TNC) with drivers who don't have specialized training in supporting healthcare riders and who don't undergo fingerprint background checks or drug and alcohol testing.

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Intervention Group: Door-through-Door RidesExperimental treatment 1 intervention
Group B: Control Group (C2C): Curb-to-Curb RidesActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Appointment Adherence

The rate of missed medical appointments (No shows and same day cancellations).

Time frame
9 Months

Secondary outcomes

1

Quality of Life (QOL)

The impact of the intervention on participants' quality of life (QOL), as measured every 3 months during the study period using the ICECAP-A (ICEpop CAPability measure for Adults) Wellbeing and Quality of Life scale. ICECAP-A has the following five attributes, each of which can take one of four levels ranging from full capability to no capability, higher scores are better outcomes: * Stability (being able to feel settled and secure) * Attachment (being able to have love, friendship and support) * Autonomy (being able to be independent) * Achievement (being able to achieve and progress) * Enjoyment (being able to have enjoyment and pleasure)

Time frame
9 months
2

Ride Acceptance Rates

Participant acceptance of the ride offered.

Time frame
9 Months
3

Ride Completion Rates

The completion rate of rides scheduled, as measured by the number of ride "No Shows" relative to rides booked.

Time frame
9 Months
4

Ride Satisfaction

Rider satisfaction with the rides received as rated on a 5 point star scale with 1 star being the lowest rating and 5 stars being the highest.

Time frame
9 Months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Onward Health, Inc

Lead sponsor

National Institute on Aging (NIA)

Collaborator

Source ClinicalTrials.gov
Apply now